- Home
- RILY vs NAGE Comparison
RILY vs NAGE Comparison
Compare RILY & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RILY | NAGE |
|---|---|---|
| Founded | 1973 | 1999 |
| Country | United States | United States |
| Employees | 1380 | 117 |
| Industry | Investment Managers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 349.8M | 290.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | RILY | NAGE |
|---|---|---|
| Price | $8.44 | $3.46 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | ★ 1.1M | 1.1M |
| Earning Date | 03-31-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $16.51 |
| Revenue Next Year | N/A | $14.58 |
| P/E Ratio | ★ $0.99 | $21.29 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.79 | $3.41 |
| 52 Week High | $11.24 | $14.66 |
Technical Indicators
Market Signals| Indicator | RILY | NAGE |
|---|---|---|
| Relative Strength Index (RSI) | 42.84 | 32.33 |
| Support Level | $8.16 | N/A |
| Resistance Level | $9.43 | $4.04 |
| Average True Range (ATR) | 0.79 | 0.18 |
| MACD | -0.20 | -0.01 |
| Stochastic Oscillator | 0.71 | 8.59 |
Price Performance
Historical ComparisonAbout RILY B. Riley Financial Inc.
BRC Group Holdings Inc is a diversified holding company offering a platform of businesses, including financial services (with complementary banking and wealth management businesses), telecom, retail, and investments in equity, debt, and venture capital. It serves retail, corporate, capital providers, and individual customers across different business lines. The Group reports its activities in seven reportable business segments: Capital Markets, Wealth Management, Lingo, magicJack, Marconi Wireless, UOL, and Consumer Products. Maximum revenue is generated from the Consumer Products segment, which offers mobile computing accessories and home furnishing products. Geographically, the Group derives its revenue from North America.
About NAGE Niagen Bioscience Inc.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.